Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sopharma AD Earnings Release 2018

Oct 5, 2018

2543_rns_2018-10-05_8f25980c-e569-4945-a937-bdd764bef260.pdf

Earnings Release

Open in viewer

Opens in your device viewer

Current report No. 120 / 2018 Dated 5 October 2018

NOTIFICATION

Sopharma AD (the "Company") notifies that for September 2018 the Company recorded decrease of sales revenues of 7% compared to the same month of 2017, including 55% increase of domestic sales and a decrease of 28% of export sales.

Revenue in the third quarter of 2018 increases compared to the same period in 2017, respectively, by 5%, incl. 10% increase of sales for the domestic market and 2% increase in export sales. Successful work during the quarter contributes to reducing the rate of decline in revenue and for the first nine months of this year, revenues from sales of products decreased by 4% (8% as at 30.06.2018) compared to the same period of 2017, including 1% decrease of domestic sales and 6% decrease of export sales.

Signatures of individuals authorized to represent the Company:

Ognian Donev